MR

Munangi Rajeshwar

Active Director Designated Partner DIN 10204065
DIN 10204065 First appointment Jun 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Munangi Rajeshwar

Data last updated:

Munangi Rajeshwar is a Designated Partner at Rg Sri Laxmi Multi Speciality Hospital Llp (since 2023). The company operates in Healthcare.

DIN 10204065
Primary Designation Designated Partner
Industry Healthcare
First Appointment 12 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Jun 20232023Active

Board colleagues of Munangi Rajeshwar

NameDINCompanyDesignation
Gurumurthy Polucherla09274193Rg Sri Laxmi Multi Speciality Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rg Sri Laxmi Multi Speciality Hospital Llp
Premium access

Shareholding and investment profile for Munangi Rajeshwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Munangi Rajeshwar

Munangi Rajeshwar currently holds 1 directorship: Rg Sri Laxmi Multi Speciality Hospital Llp (Designated Partner, since 12 Jun 2023).

Munangi Rajeshwar was first appointed on 12 Jun 2023 as Designated Partner at Rg Sri Laxmi Multi Speciality Hospital Llp.

The current boards of Munangi Rajeshwar's companies include Gurumurthy Polucherla (Rg Sri Laxmi Multi Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available